Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vortioxetine Versus Sertraline in Control Metabolic, Distress and Depression in Mexican Patients With Type 2 Diabetes

NCT03978286 is registered in ClinicalTrials.gov with Universidad Juárez Autónoma de Tabasco as lead sponsor.

NCT NCT03978286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03978286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vortioxetine Versus Sertraline in Control Metabolic, Distress and Depression in Mexican Patients With Type 2 Diabetes
Lead sponsor
Universidad Juárez Autónoma de Tabasco
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2016
Completion date
June 30, 2018
Enrollment
21 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

depression, type 2 diabetes mellitus